tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. 2015 Ann. Intern. Med. pmid:25383607
Farnik H et al. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation. 2015 Liver Int. pmid:24649882
Fukahori H et al. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation. 2015 Int. Immunopharmacol. pmid:26122135
Langone A et al. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study. 2015 Clin Transplant pmid:26113208
Plock JA et al. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. 2015 Transplantation pmid:26102613
Castaneda J and Matzuk MM DEVELOPMENTAL BIOLOGY. Toward a rapid and reversible male pill. 2015 Science pmid:26494747
Carenco C et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. 2015 Liver Int. pmid:25488375
Garcia C et al. Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013. 2015 Transplant. Proc. pmid:26036492
Melo MJ et al. Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study. 2015 Transplant. Proc. pmid:26036484
Miyata H et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive. 2015 Science pmid:26429887
Meyer C et al. Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. 2015 Clin. Exp. Immunol. pmid:25902927
Sassi MB et al. Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report. 2015 Curr Drug Saf pmid:25968921
Bifano M et al. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects. 2015 Clin Drug Investig pmid:25896946
Wang CY et al. Analysis of tacrolimus blood concentrations in renal transplant patients. 2015 Genet. Mol. Res. pmid:25966149
Caro J et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. 2015 Nephrol. Dial. Transplant. pmid:25274748
Wang L et al. Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. 2015 Genet. Mol. Res. pmid:25966085
Bedi M and Taylor AL Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A. 2015 Cutis pmid:26761940
Colak H et al. Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. 2015 Transplant. Proc. pmid:25964218
Antonini TM et al. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. 2015 AIDS pmid:25387314
Gallon L et al. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. 2015 Transplantation pmid:25905982
Chen KH et al. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor. 2015 J. Formos. Med. Assoc. pmid:25843527
Berro M et al. Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality. 2015 Medicina (B Aires) pmid:26339873
Gajzlerska W et al. Use of three-carbon chain compounds as biosynthesis precursors to enhance tacrolimus production in Streptomyces tsukubaensis. 2015 N Biotechnol pmid:25152525
Robertsen I et al. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. 2015 Transplantation pmid:25148382
Yu Z et al. IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. 2015 Mol Med Rep pmid:25333459
Tajdaran K et al. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). 2015 Biotechnol. Bioeng. pmid:25850693
Jacobo-Cabral CO et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. 2015 Br J Clin Pharmacol pmid:25846845
Wang L et al. Gq signaling causes glomerular injury by activating TRPC6. 2015 J. Clin. Invest. pmid:25844902
Bowman LJ et al. Tacrolimus-Induced Cardiomyopathy in an Adult Renal Transplant Recipient. 2015 Pharmacotherapy pmid:26616582
Miguel-Gómez L et al. [Peristomal pyoderma gangrenosum associated with colon cancer]. 2015 Med Clin (Barc) pmid:25659860
Aouam K et al. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase. 2015 Pharmacogenomics pmid:26615671
Girdlestone J et al. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs. 2015 Cytotherapy pmid:26276002
Ross A and Kirsner RS JID VisualDx Quiz: April 2015. 2015 J. Invest. Dermatol. pmid:25785952
Tavira B et al. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: a Next Generation Sequencing approach. 2015 Clin. Chem. Lab. Med. pmid:25781547
Plischke M et al. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. 2015 PLoS ONE pmid:26270340
Chen F et al. [Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria]. 2015 Zhonghua Xue Ye Xue Za Zhi pmid:26759101
Fan J et al. Donor IL-18 rs5744247 polymorphism as a new biomarker of tacrolimus elimination in Chinese liver transplant patients during the early post-transplantation period: results from two cohort studies. 2015 Pharmacogenomics pmid:25712187
Morales E et al. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab. 2015 Transpl. Int. pmid:25712140
Buschow SI et al. To target or not to target viral antigens in HBV related HCC? 2015 J. Hepatol. pmid:25711422
Jia N et al. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. 2015 BMC Cancer pmid:26197890
Duong SQ et al. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients. 2015 Pediatr Transplant pmid:26497983
Kawano N et al. Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus. 2015 J Clin Exp Hematop pmid:26490521
Pucci N et al. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. 2015 Pediatr Allergy Immunol pmid:25712437
Kim KW et al. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. 2015 Immunology pmid:24974886
Van der Perren A et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. 2015 Neurobiol. Aging pmid:25660193
Ayala E et al. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma. 2015 Clin Lymphoma Myeloma Leuk pmid:25659459
Stefanović NZ et al. Potential role of tacrolimus in erythrocytes' antioxidative capacity in long-term period after renal transplantation. 2015 Eur J Pharm Sci pmid:25657088
Petruzzo P et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. 2015 Ann. Surg. pmid:24646555
Polańska A et al. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography. 2015 Skin Res Technol pmid:24894324
Garnock-Jones KP Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. 2015 Drugs pmid:25613762
Li CJ and Li L Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use. 2015 Drug Des Devel Ther pmid:25609922
Uemoto S et al. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients. 2015 Clin. Exp. Immunol. pmid:25603847
Oda K et al. In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure. 2015 Biopharm Drug Dispos pmid:25600613
de Jonge H et al. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. 2015 Br J Clin Pharmacol pmid:26114223
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Rojas-Vega L et al. Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort. 2015 Am. J. Physiol. Renal Physiol. pmid:26336164
Sánchez-Lázaro I et al. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation. 2015 Pharmacogenomics pmid:26107754
Teixeira Mdo C et al. Influence of post-transplant immunosuppressive therapy on gastrointestinal transit using biomagnetic method: a pilot study. 2015 Dig. Dis. Sci. pmid:25146844
Urquhart BL and Knauer MJ Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients. 2015 Pediatr Transplant pmid:25546506
Minami-Hori M et al. Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone. 2015 J. Dermatol. pmid:25544984
Pagliarello C et al. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison. 2015 Eur J Dermatol pmid:25786341
Xing J et al. Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients. 2015 Eur. J. Clin. Pharmacol. pmid:25487141
Muduma G et al. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK. 2015 J Med Econ pmid:26201252
Mizuno K et al. Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model. 2015 J. Dermatol. Sci. pmid:26198442
Niioka T et al. Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. 2015 Xenobiotica pmid:26189776
Rathi M et al. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. 2015 Transplant. Proc. pmid:26036543
Mohsin N et al. Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. 2015 Transplant. Proc. pmid:26036534
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Gołębiewska J et al. Tako-tsubo cardiomyopathy on the first day after renal transplantation - case report and literature review. 2014 Transplant. Proc. pmid:25380951
Ünlüsoy Aksu A et al. Immune thrombocytopenic purpura in a liver transplant patient. 2014 Exp Clin Transplant pmid:24635822
Bakkour W et al. Successful use of dapsone for the management of circinate balanitis. 2014 Clin. Exp. Dermatol. pmid:24635073
Kapoor K et al. Lip hypertrophy due to cyclosporine therapy. 2014 Clin. Exp. Nephrol. pmid:23615783
Naganuma M et al. [Clinical relevance of tacrolimus trough levels in outpatients with active ulcerative colitis]. 2014 Nihon Shokakibyo Gakkai Zasshi pmid:24500317
Sahin S et al. The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation. 2014 Fertil. Steril. pmid:24502894
Xu H et al. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. 2014 Am. J. Transplant. pmid:24472192
Lankarani KB et al. Response to: Comment on: New-onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. 2014 Exp Clin Transplant pmid:24471728
Kuypers DR et al. Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. 2014 Pharmacogenet. Genomics pmid:25322286
Iwanami M et al. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis]. 2014 Rinsho Shinkeigaku pmid:24429649
Urbanowicz T et al. Induction therapy, tacrolimus plasma concentration, and duration if intensive care unit stay are risk factors for peripheral leucopenia following heart transplantation. 2014 Ann. Transplant. pmid:25274118
Kujawski S et al. Calcineurin regulates coordinated outgrowth of zebrafish regenerating fins. 2014 Dev. Cell pmid:24561038
Eguchi R et al. Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation. 2014 Exp. Cell Res. pmid:24582967
Sun Z et al. Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics. 2014 Int Urol Nephrol pmid:25145781
Dannhorn E et al. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up. 2014 Clin Transplant pmid:25142496
Calo S et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. 2014 Nature pmid:25079329
Matin M et al. The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population. 2014 J Cosmet Laser Ther pmid:25046236
de la Fuente V et al. Calcineurin phosphatase as a negative regulator of fear memory in hippocampus: control on nuclear factor-κB signaling in consolidation and reconsolidation. 2014 Hippocampus pmid:25043904
Qi H et al. Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis. 2014 J. Ind. Microbiol. Biotechnol. pmid:24965502
Song L et al. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys. 2014 Transplantation pmid:24992357
Nafar M et al. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients. 2014 Iran J Kidney Dis pmid:24878947
van Gelder T Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation. 2014 Kidney Int. pmid:24875549
Maeda H et al. Disappearance of GFP-positive hepatocytes transplanted into the liver of syngeneic wild-type rats pretreated with retrorsine. 2014 PLoS ONE pmid:24796859
Du W et al. Improved FK506 production by the precursors and product-tolerant mutant of Streptomyces tsukubaensis based on genome shuffling and dynamic fed-batch strategies. 2014 J. Ind. Microbiol. Biotechnol. pmid:24788378
Nkongolo S et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. 2014 J. Hepatol. pmid:24295872
Pandey S et al. Metabotropic glutamate receptor 1 recycles to the cell surface in protein phosphatase 2A-dependent manner in non-neuronal and neuronal cell lines. 2014 J. Neurochem. pmid:25113668
Madian AG et al. Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution. 2014 BMC Pharmacol Toxicol pmid:25472557
Indriolo A and Ravelli P Clinical management of inflammatory bowel disease in the organ recipient. 2014 World J. Gastroenterol. pmid:24707135
Lee SK et al. Overexpression of the putative extracytoplasmic function sigma (σ) factor FujE enhances FK506 production in Streptomyces sp. strain KCCM 11116P. 2014 Can. J. Microbiol. pmid:24869633